Continuing progress on vasomotor symptoms

被引:0
|
作者
Barlow, David H. [1 ,2 ]
机构
[1] Univ Glasgow, Glasgow, Scotland
[2] Oriel Coll, Oriel Sq, Oxford OX1 4EW, England
来源
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2023年 / 30卷 / 03期
关键词
MENOPAUSAL FLUSHES; DOUBLE-BLIND; NEURONS; SECRETION;
D O I
10.1097/GME.0000000000002160
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:235 / 236
页数:2
相关论文
共 50 条
  • [31] Effective herbal treatment of vasomotor symptoms-are we any closer?
    Kaunitz, Andrew M.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2009, 16 (03): : 428 - 429
  • [32] Low-dose transdermal estradiol for vasomotor symptoms: a systematic review
    Corbelli, Jennifer
    Shaikh, Nader
    Wessel, Charles
    Hess, Rachel
    MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY, 2015, 22 (01): : 114 - 121
  • [33] Fezolinetant for the treatment of vasomotor symptoms associated with menopause: a meta-analysis
    Chavez, Matheus Pedrotti
    Pasqualotto, Eric
    Ferreira, Rafael Oliva Morgado
    Hohl, Alexandre
    de Moraes, Francisco Cezar Aquino
    Schmidt, Pedro Henrique Siedschlag
    Rodrigues, Anna Luiza Soares de Oliveira
    de Sa, Joao Roberto
    CLIMACTERIC, 2024, 27 (03) : 245 - 254
  • [34] Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause A Randomized Controlled Trial
    Neal-Perry, Genevieve
    Cano, Antonio
    Lederman, Samuel
    Nappi, Rossella E.
    Santoro, Nanette
    Wolfman, Wendy
    English, Marci
    Franklin, Catherine
    Valluri, Udaya
    Ottery, Faith D.
    OBSTETRICS AND GYNECOLOGY, 2023, 141 (04) : 737 - 747
  • [35] Vasomotor Symptoms: Viewpoint from the Indian Subcontinent and Management of a Common Menopausal Problem
    Shah, Duru
    Agrawal, Sangeeta
    SEMINARS IN REPRODUCTIVE MEDICINE, 2010, 28 (05) : 388 - 395
  • [36] EMAS position statement: Non-hormonal management of menopausal vasomotor symptoms
    Mintziori, Gesthimani
    Lambrinoudaki, Irene
    Goulis, Dimitrios G.
    Ceausu, Iuliana
    Depypere, Herman
    Erel, C. Tamer
    Perez-Lopez, Faustino R.
    Schenck-Gustafsson, Karin
    Simoncini, Tommaso
    Tremollieres, Florence
    Rees, Margaret
    MATURITAS, 2015, 81 (03) : 410 - 413
  • [37] Vortioxetine for major depressive disorder, vasomotor, and cognitive symptoms associated with the menopausal transition
    Freeman, Marlene P.
    Cheng, Laura J.
    Moustafa, Danna
    Davies, Abigail
    Sosinsky, Alexandra Z.
    Wang, Betty
    Petrillo, Laura F.
    Hogan, Charlotte
    Cohen, Lee S.
    ANNALS OF CLINICAL PSYCHIATRY, 2017, 29 (04) : 249 - 257
  • [38] Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial
    Cohen, Lee S.
    Joffe, Hadine
    Guthrie, Katherine A.
    Ensrud, Kristine E.
    Freeman, Marlene
    Carpenter, Janet S.
    Learman, Lee A.
    Newton, Katherine M.
    Reed, Susan D.
    Manson, JoAnn E.
    Sternfeld, Barbara
    Caan, Bette
    Freeman, Ellen W.
    LaCroix, Andrea Z.
    Tinker, Lesley F.
    Booth-LaForce, Cathryn
    Larson, Joseph C.
    Anderson, Garnet L.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2014, 21 (04): : 347 - 354
  • [39] The role of kisspeptin/neurokinin B/dynorphin neurons in pathomechanism of vasomotor symptoms in postmenopausal women: from physiology to potential therapeutic applications
    Szeliga, Anna
    Czyzyk, Adam
    Podfigurna, Agnieszka
    Genazzani, Andrea R.
    Genazzani, Alessandro D.
    Meczekalski, Blazej
    GYNECOLOGICAL ENDOCRINOLOGY, 2018, 34 (11) : 913 - 919
  • [40] Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms
    Bouchard, P.
    Panay, N.
    de Villiers, T. J.
    Vincendon, P.
    Bao, W.
    Cheng, R. J.
    Constantine, G.
    CLIMACTERIC, 2012, 15 (01) : 12 - 20